Hypermobility Syndrome Support Protocol
Primary Stack
Core supplements with strongest evidenceProvides building blocks for connective tissue; may support joint stability
Supporting Studies (1)
Essential cofactor for collagen synthesis
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsSupports muscle function; may help with cramping and pain
Supporting Studies (1)
Anti-inflammatory; may help with joint pain
Supporting Studies (1)
May support cartilage health in hypermobile joints prone to wear
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Hypermobility syndrome (also called joint hypermobility syndrome or hypermobile Ehlers-Danlos syndrome) is a condition where joints easily move beyond the normal range. While some hypermobility is harmless, it can cause pain and problems for many people.
SYMPTOMS:
TYPES:
KEY MANAGEMENT:
IMPORTANT:
* Collagen and vitamin C support connective tissue.
* Physical therapy is most important treatment.
* Strengthening exercises protect joints.
Expected timeline: Management is ongoing. Supplements may support connective tissue health with consistent use over months.
Clinical Perspective
Hypermobility: Ranges from benign to hypermobile EDS (hEDS). Diagnosis: Beighton score + systemic criteria. hEDS: most common EDS; no genetic test available. Associated: POTS, fatigue, GI dysmotility, anxiety.
Management: Physical therapy is cornerstone - proprioceptive training, strengthening, joint protection. Low-impact exercise (swimming, Pilates). Bracing for unstable joints. Pain management multimodal. Supplements: collagen theoretical benefit (provides substrates); vitamin C essential for collagen synthesis; limited direct evidence in hypermobility. PT most evidence-based intervention.
* Collagen (C-grade): Connective tissue. Systematic review: (PMID: 30681787). 10-15g daily.
* Vitamin C (B-grade): Collagen synthesis. Review: (PMID: 23440782). 500-1000mg daily.
* Magnesium (C-grade): Muscle function. Review: (PMID: 28445426). 300-400mg daily.
* Omega-3 (C-grade): Anti-inflammatory. Systematic review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Glucosamine/Chondroitin (C-grade): Cartilage. Cochrane: (PMID: 20847017). 1500mg/1200mg daily.
Protocol notes: Physical therapy: most important; strengthening, not stretching; proprioceptive training. Exercise: low-impact; avoid hyperextension; swimming excellent. POTS: common comorbidity; increase salt/fluid, compression. Pain: multimodal; pacing important. Sleep: often disrupted; address sleep hygiene. Fatigue: very common; pacing, energy conservation. GI: dysmotility common; dietary modifications. Psychology: chronic pain support; anxiety common. Genetics: hEDS has no genetic test; other EDS types do.